Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

July 01, 2012; Volume 82,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Almazrooa, Soulafa A.

    1. You have access
      Muscarinic Type 3 Receptor Induces Cytoprotective Signaling in Salivary Gland Cells through Epidermal Growth Factor Receptor Transactivation
      Mikihito Kajiya, Isao Ichimonji, Christine Min, Tongbo Zhu, Jun-O Jin, Qing Yu, Soulafa A. Almazrooa, Seunghee Cha and Toshihisa Kawai
      Molecular Pharmacology July 2012, 82 (1) 115-124; DOI: https://doi.org/10.1124/mol.111.077354
  2. Ambudkar, Suresh V.

    1. You have access
      Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299
  3. Anderson, Karen S.

    1. You have access
      Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase
      Christal D. Sohl, Rajesh Kasiviswanathan, Jiae Kim, Ugo Pradere, Raymond F. Schinazi, William C. Copeland, Hiroaki Mitsuya, Masanori Baba and Karen S. Anderson
      Molecular Pharmacology July 2012, 82 (1) 125-133; DOI: https://doi.org/10.1124/mol.112.078758
  4. Auzanneau, Céline

    1. You have access
      The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537

B

  1. Baba, Masanori

    1. You have access
      Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase
      Christal D. Sohl, Rajesh Kasiviswanathan, Jiae Kim, Ugo Pradere, Raymond F. Schinazi, William C. Copeland, Hiroaki Mitsuya, Masanori Baba and Karen S. Anderson
      Molecular Pharmacology July 2012, 82 (1) 125-133; DOI: https://doi.org/10.1124/mol.112.078758
  2. Basha, Maram Talal

    1. You have access
      Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect
      Patricia Quach, Elaine Gutierrez, Maram Talal Basha, Danuta S. Kalinowski, Philip C. Sharpe, David B. Lovejoy, Paul V. Bernhardt, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology July 2012, 82 (1) 105-114; DOI: https://doi.org/10.1124/mol.112.078964
  3. Berger, Joel P.

    1. You have access
      Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679
  4. Berlin, Joshua R.

    1. You have access
      Membrane Potential-Dependent Inhibition of the Na+,K+-ATPase by para-Nitrobenzyltriethylammonium Bromide
      R. Daniel Peluffo and Joshua R. Berlin
      Molecular Pharmacology July 2012, 82 (1) 1-8; DOI: https://doi.org/10.1124/mol.111.077008
  5. Bernhardt, Paul V.

    1. You have access
      Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect
      Patricia Quach, Elaine Gutierrez, Maram Talal Basha, Danuta S. Kalinowski, Philip C. Sharpe, David B. Lovejoy, Paul V. Bernhardt, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology July 2012, 82 (1) 105-114; DOI: https://doi.org/10.1124/mol.112.078964
  6. Boni-Mitake, Malvina

    1. You have access
      Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of KV Channels
      Steve Peigneur, Diego J. B. Orts, Alvaro R. Prieto da Silva, Nancy Oguiura, Malvina Boni-Mitake, Eduardo B. de Oliveira, André J. Zaharenko, Jose C. de Freitas and Jan Tytgat
      Molecular Pharmacology July 2012, 82 (1) 90-96; DOI: https://doi.org/10.1124/mol.112.078188

C

  1. Cha, Seunghee

    1. You have access
      Muscarinic Type 3 Receptor Induces Cytoprotective Signaling in Salivary Gland Cells through Epidermal Growth Factor Receptor Transactivation
      Mikihito Kajiya, Isao Ichimonji, Christine Min, Tongbo Zhu, Jun-O Jin, Qing Yu, Soulafa A. Almazrooa, Seunghee Cha and Toshihisa Kawai
      Molecular Pharmacology July 2012, 82 (1) 115-124; DOI: https://doi.org/10.1124/mol.111.077354
  2. Chen, Xing-gui

    1. You have access
      Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299
  3. Chen, Zhe-Sheng

    1. You have access
      Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299
  4. Cohen-Tannoudji, Joelle

    1. You have access
      Influence of the Accessory Protein SET on M3 Muscarinic Receptor Phosphorylation and G Protein Coupling
      Violaine Simon, Sukru S. Oner, Joelle Cohen-Tannoudji, Andrew B. Tobin and Stephen M. Lanier
      Molecular Pharmacology July 2012, 82 (1) 17-26; DOI: https://doi.org/10.1124/mol.111.075523
  5. Copeland, William C.

    1. You have access
      Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase
      Christal D. Sohl, Rajesh Kasiviswanathan, Jiae Kim, Ugo Pradere, Raymond F. Schinazi, William C. Copeland, Hiroaki Mitsuya, Masanori Baba and Karen S. Anderson
      Molecular Pharmacology July 2012, 82 (1) 125-133; DOI: https://doi.org/10.1124/mol.112.078758

D

  1. Dai, Hongyue

    1. You have access
      Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679
  2. Deffieux, Denis

    1. You have access
      The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537
  3. de Freitas, Jose C.

    1. You have access
      Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of KV Channels
      Steve Peigneur, Diego J. B. Orts, Alvaro R. Prieto da Silva, Nancy Oguiura, Malvina Boni-Mitake, Eduardo B. de Oliveira, André J. Zaharenko, Jose C. de Freitas and Jan Tytgat
      Molecular Pharmacology July 2012, 82 (1) 90-96; DOI: https://doi.org/10.1124/mol.112.078188
  4. De Giorgi, Francesca

    1. You have access
      The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537
  5. de Oliveira, Eduardo B.

    1. You have access
      Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of KV Channels
      Steve Peigneur, Diego J. B. Orts, Alvaro R. Prieto da Silva, Nancy Oguiura, Malvina Boni-Mitake, Eduardo B. de Oliveira, André J. Zaharenko, Jose C. de Freitas and Jan Tytgat
      Molecular Pharmacology July 2012, 82 (1) 90-96; DOI: https://doi.org/10.1124/mol.112.078188
  6. Diepold, Maximilian

    1. You have access
      Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia
      Ekaitz Errasti-Murugarren, Paula Fernández-Calotti, Mayke Veyhl-Wichmann, Maximilian Diepold, Itziar Pinilla-Macua, Sandra Pérez-Torras, Helmut Kipp, Hermann Koepsell and Marçal Pastor-Anglada
      Molecular Pharmacology July 2012, 82 (1) 59-67; DOI: https://doi.org/10.1124/mol.111.076992

E

  1. Elkaoukabi-Chaibi, Assia

    1. You have access
      The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537
  2. Eloranta, Jyrki J.

    1. You have access
      The SLCO1A2 Gene, Encoding Human Organic Anion-Transporting Polypeptide 1A2, Is Transactivated by the Vitamin D Receptor
      Jyrki J. Eloranta, Christian Hiller, Moritz Jüttner and Gerd A. Kullak-Ublick
      Molecular Pharmacology July 2012, 82 (1) 37-46; DOI: https://doi.org/10.1124/mol.112.077909
  3. Errasti-Murugarren, Ekaitz

    1. You have access
      Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia
      Ekaitz Errasti-Murugarren, Paula Fernández-Calotti, Mayke Veyhl-Wichmann, Maximilian Diepold, Itziar Pinilla-Macua, Sandra Pérez-Torras, Helmut Kipp, Hermann Koepsell and Marçal Pastor-Anglada
      Molecular Pharmacology July 2012, 82 (1) 59-67; DOI: https://doi.org/10.1124/mol.111.076992

F

  1. Fernández-Calotti, Paula

    1. You have access
      Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia
      Ekaitz Errasti-Murugarren, Paula Fernández-Calotti, Mayke Veyhl-Wichmann, Maximilian Diepold, Itziar Pinilla-Macua, Sandra Pérez-Torras, Helmut Kipp, Hermann Koepsell and Marçal Pastor-Anglada
      Molecular Pharmacology July 2012, 82 (1) 59-67; DOI: https://doi.org/10.1124/mol.111.076992
  2. Fu, Li-wu

    1. You have access
      Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299

G

  1. Gutierrez, Elaine

    1. You have access
      Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect
      Patricia Quach, Elaine Gutierrez, Maram Talal Basha, Danuta S. Kalinowski, Philip C. Sharpe, David B. Lovejoy, Paul V. Bernhardt, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology July 2012, 82 (1) 105-114; DOI: https://doi.org/10.1124/mol.112.078964

H

  1. Hiller, Christian

    1. You have access
      The SLCO1A2 Gene, Encoding Human Organic Anion-Transporting Polypeptide 1A2, Is Transactivated by the Vitamin D Receptor
      Jyrki J. Eloranta, Christian Hiller, Moritz Jüttner and Gerd A. Kullak-Ublick
      Molecular Pharmacology July 2012, 82 (1) 37-46; DOI: https://doi.org/10.1124/mol.112.077909
  2. Hohl, Raymond J.

    1. You have access
      Functional Evaluation of a Fluorescent Schweinfurthin: Mechanism of Cytotoxicity and Intracellular Quantification
      Craig H. Kuder, Ryan M. Sheehy, Jeffrey D. Neighbors, David F. Wiemer and Raymond J. Hohl
      Molecular Pharmacology July 2012, 82 (1) 9-16; DOI: https://doi.org/10.1124/mol.111.077107

I

  1. Ichas, François

    1. You have access
      The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537
  2. Ichimonji, Isao

    1. You have access
      Muscarinic Type 3 Receptor Induces Cytoprotective Signaling in Salivary Gland Cells through Epidermal Growth Factor Receptor Transactivation
      Mikihito Kajiya, Isao Ichimonji, Christine Min, Tongbo Zhu, Jun-O Jin, Qing Yu, Soulafa A. Almazrooa, Seunghee Cha and Toshihisa Kawai
      Molecular Pharmacology July 2012, 82 (1) 115-124; DOI: https://doi.org/10.1124/mol.111.077354
  3. Illes, Peter

    1. You have access
      Effects of Nucleotide Analogs at the P2X3 Receptor and Its Mutants Identify the Agonist Binding Pouch
      Thomas Riedel, Sara Wiese, Anna Leichsenring and Peter Illes
      Molecular Pharmacology July 2012, 82 (1) 80-89; DOI: https://doi.org/10.1124/mol.112.077818

J

  1. Jacquet, Rémi

    1. You have access
      The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537
  2. Jansson, Patric J.

    1. You have access
      Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect
      Patricia Quach, Elaine Gutierrez, Maram Talal Basha, Danuta S. Kalinowski, Philip C. Sharpe, David B. Lovejoy, Paul V. Bernhardt, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology July 2012, 82 (1) 105-114; DOI: https://doi.org/10.1124/mol.112.078964
  3. Jin, Jun-O

    1. You have access
      Muscarinic Type 3 Receptor Induces Cytoprotective Signaling in Salivary Gland Cells through Epidermal Growth Factor Receptor Transactivation
      Mikihito Kajiya, Isao Ichimonji, Christine Min, Tongbo Zhu, Jun-O Jin, Qing Yu, Soulafa A. Almazrooa, Seunghee Cha and Toshihisa Kawai
      Molecular Pharmacology July 2012, 82 (1) 115-124; DOI: https://doi.org/10.1124/mol.111.077354
  4. Jüttner, Moritz

    1. You have access
      The SLCO1A2 Gene, Encoding Human Organic Anion-Transporting Polypeptide 1A2, Is Transactivated by the Vitamin D Receptor
      Jyrki J. Eloranta, Christian Hiller, Moritz Jüttner and Gerd A. Kullak-Ublick
      Molecular Pharmacology July 2012, 82 (1) 37-46; DOI: https://doi.org/10.1124/mol.112.077909

K

  1. Kajiya, Mikihito

    1. You have access
      Muscarinic Type 3 Receptor Induces Cytoprotective Signaling in Salivary Gland Cells through Epidermal Growth Factor Receptor Transactivation
      Mikihito Kajiya, Isao Ichimonji, Christine Min, Tongbo Zhu, Jun-O Jin, Qing Yu, Soulafa A. Almazrooa, Seunghee Cha and Toshihisa Kawai
      Molecular Pharmacology July 2012, 82 (1) 115-124; DOI: https://doi.org/10.1124/mol.111.077354
  2. Kalinowski, Danuta S.

    1. You have access
      Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect
      Patricia Quach, Elaine Gutierrez, Maram Talal Basha, Danuta S. Kalinowski, Philip C. Sharpe, David B. Lovejoy, Paul V. Bernhardt, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology July 2012, 82 (1) 105-114; DOI: https://doi.org/10.1124/mol.112.078964
  3. Kasiviswanathan, Rajesh

    1. You have access
      Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase
      Christal D. Sohl, Rajesh Kasiviswanathan, Jiae Kim, Ugo Pradere, Raymond F. Schinazi, William C. Copeland, Hiroaki Mitsuya, Masanori Baba and Karen S. Anderson
      Molecular Pharmacology July 2012, 82 (1) 125-133; DOI: https://doi.org/10.1124/mol.112.078758
  4. Kawai, Toshihisa

    1. You have access
      Muscarinic Type 3 Receptor Induces Cytoprotective Signaling in Salivary Gland Cells through Epidermal Growth Factor Receptor Transactivation
      Mikihito Kajiya, Isao Ichimonji, Christine Min, Tongbo Zhu, Jun-O Jin, Qing Yu, Soulafa A. Almazrooa, Seunghee Cha and Toshihisa Kawai
      Molecular Pharmacology July 2012, 82 (1) 115-124; DOI: https://doi.org/10.1124/mol.111.077354
  5. Kim, Jiae

    1. You have access
      Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase
      Christal D. Sohl, Rajesh Kasiviswanathan, Jiae Kim, Ugo Pradere, Raymond F. Schinazi, William C. Copeland, Hiroaki Mitsuya, Masanori Baba and Karen S. Anderson
      Molecular Pharmacology July 2012, 82 (1) 125-133; DOI: https://doi.org/10.1124/mol.112.078758
  6. Kim, Sang Geon

    1. You have access
      Fyn Inhibition by Cycloalkane-Fused 1,2-Dithiole-3-thiones Enhances Antioxidant Capacity and Protects Mitochondria from Oxidative Injury
      Ja Hyun Koo, Woo Hyung Lee, Chan Gyu Lee and Sang Geon Kim
      Molecular Pharmacology July 2012, 82 (1) 27-36; DOI: https://doi.org/10.1124/mol.111.077149
  7. Kipp, Helmut

    1. You have access
      Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia
      Ekaitz Errasti-Murugarren, Paula Fernández-Calotti, Mayke Veyhl-Wichmann, Maximilian Diepold, Itziar Pinilla-Macua, Sandra Pérez-Torras, Helmut Kipp, Hermann Koepsell and Marçal Pastor-Anglada
      Molecular Pharmacology July 2012, 82 (1) 59-67; DOI: https://doi.org/10.1124/mol.111.076992
  8. Koepsell, Hermann

    1. You have access
      Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia
      Ekaitz Errasti-Murugarren, Paula Fernández-Calotti, Mayke Veyhl-Wichmann, Maximilian Diepold, Itziar Pinilla-Macua, Sandra Pérez-Torras, Helmut Kipp, Hermann Koepsell and Marçal Pastor-Anglada
      Molecular Pharmacology July 2012, 82 (1) 59-67; DOI: https://doi.org/10.1124/mol.111.076992
  9. Koo, Ja Hyun

    1. You have access
      Fyn Inhibition by Cycloalkane-Fused 1,2-Dithiole-3-thiones Enhances Antioxidant Capacity and Protects Mitochondria from Oxidative Injury
      Ja Hyun Koo, Woo Hyung Lee, Chan Gyu Lee and Sang Geon Kim
      Molecular Pharmacology July 2012, 82 (1) 27-36; DOI: https://doi.org/10.1124/mol.111.077149
  10. Kuder, Craig H.

    1. You have access
      Functional Evaluation of a Fluorescent Schweinfurthin: Mechanism of Cytotoxicity and Intracellular Quantification
      Craig H. Kuder, Ryan M. Sheehy, Jeffrey D. Neighbors, David F. Wiemer and Raymond J. Hohl
      Molecular Pharmacology July 2012, 82 (1) 9-16; DOI: https://doi.org/10.1124/mol.111.077107
  11. Kullak-Ublick, Gerd A.

    1. You have access
      The SLCO1A2 Gene, Encoding Human Organic Anion-Transporting Polypeptide 1A2, Is Transactivated by the Vitamin D Receptor
      Jyrki J. Eloranta, Christian Hiller, Moritz Jüttner and Gerd A. Kullak-Ublick
      Molecular Pharmacology July 2012, 82 (1) 37-46; DOI: https://doi.org/10.1124/mol.112.077909

L

  1. Lanier, Stephen M.

    1. You have access
      Influence of the Accessory Protein SET on M3 Muscarinic Receptor Phosphorylation and G Protein Coupling
      Violaine Simon, Sukru S. Oner, Joelle Cohen-Tannoudji, Andrew B. Tobin and Stephen M. Lanier
      Molecular Pharmacology July 2012, 82 (1) 17-26; DOI: https://doi.org/10.1124/mol.111.075523
  2. Lee, Chan Gyu

    1. You have access
      Fyn Inhibition by Cycloalkane-Fused 1,2-Dithiole-3-thiones Enhances Antioxidant Capacity and Protects Mitochondria from Oxidative Injury
      Ja Hyun Koo, Woo Hyung Lee, Chan Gyu Lee and Sang Geon Kim
      Molecular Pharmacology July 2012, 82 (1) 27-36; DOI: https://doi.org/10.1124/mol.111.077149
  3. Lee, Woo Hyung

    1. You have access
      Fyn Inhibition by Cycloalkane-Fused 1,2-Dithiole-3-thiones Enhances Antioxidant Capacity and Protects Mitochondria from Oxidative Injury
      Ja Hyun Koo, Woo Hyung Lee, Chan Gyu Lee and Sang Geon Kim
      Molecular Pharmacology July 2012, 82 (1) 27-36; DOI: https://doi.org/10.1124/mol.111.077149
  4. Leichsenring, Anna

    1. You have access
      Effects of Nucleotide Analogs at the P2X3 Receptor and Its Mutants Identify the Agonist Binding Pouch
      Thomas Riedel, Sara Wiese, Anna Leichsenring and Peter Illes
      Molecular Pharmacology July 2012, 82 (1) 80-89; DOI: https://doi.org/10.1124/mol.112.077818
  5. Liang, Yong-ju

    1. You have access
      Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299
  6. Lovejoy, David B.

    1. You have access
      Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect
      Patricia Quach, Elaine Gutierrez, Maram Talal Basha, Danuta S. Kalinowski, Philip C. Sharpe, David B. Lovejoy, Paul V. Bernhardt, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology July 2012, 82 (1) 105-114; DOI: https://doi.org/10.1124/mol.112.078964
  7. Lum, Pek Yee

    1. You have access
      Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679

M

  1. Meinke, Peter T.

    1. You have access
      Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679
  2. Min, Christine

    1. You have access
      Muscarinic Type 3 Receptor Induces Cytoprotective Signaling in Salivary Gland Cells through Epidermal Growth Factor Receptor Transactivation
      Mikihito Kajiya, Isao Ichimonji, Christine Min, Tongbo Zhu, Jun-O Jin, Qing Yu, Soulafa A. Almazrooa, Seunghee Cha and Toshihisa Kawai
      Molecular Pharmacology July 2012, 82 (1) 115-124; DOI: https://doi.org/10.1124/mol.111.077354
  3. Mitsuya, Hiroaki

    1. You have access
      Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase
      Christal D. Sohl, Rajesh Kasiviswanathan, Jiae Kim, Ugo Pradere, Raymond F. Schinazi, William C. Copeland, Hiroaki Mitsuya, Masanori Baba and Karen S. Anderson
      Molecular Pharmacology July 2012, 82 (1) 125-133; DOI: https://doi.org/10.1124/mol.112.078758
  4. Montaudon, Danièle

    1. You have access
      The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537
  5. Muise, Eric S.

    1. You have access
      Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679

N

  1. Neighbors, Jeffrey D.

    1. You have access
      Functional Evaluation of a Fluorescent Schweinfurthin: Mechanism of Cytotoxicity and Intracellular Quantification
      Craig H. Kuder, Ryan M. Sheehy, Jeffrey D. Neighbors, David F. Wiemer and Raymond J. Hohl
      Molecular Pharmacology July 2012, 82 (1) 9-16; DOI: https://doi.org/10.1124/mol.111.077107

O

  1. Oguiura, Nancy

    1. You have access
      Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of KV Channels
      Steve Peigneur, Diego J. B. Orts, Alvaro R. Prieto da Silva, Nancy Oguiura, Malvina Boni-Mitake, Eduardo B. de Oliveira, André J. Zaharenko, Jose C. de Freitas and Jan Tytgat
      Molecular Pharmacology July 2012, 82 (1) 90-96; DOI: https://doi.org/10.1124/mol.112.078188
  2. Oner, Sukru S.

    1. You have access
      Influence of the Accessory Protein SET on M3 Muscarinic Receptor Phosphorylation and G Protein Coupling
      Violaine Simon, Sukru S. Oner, Joelle Cohen-Tannoudji, Andrew B. Tobin and Stephen M. Lanier
      Molecular Pharmacology July 2012, 82 (1) 17-26; DOI: https://doi.org/10.1124/mol.111.075523
  3. Orts, Diego J. B.

    1. You have access
      Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of KV Channels
      Steve Peigneur, Diego J. B. Orts, Alvaro R. Prieto da Silva, Nancy Oguiura, Malvina Boni-Mitake, Eduardo B. de Oliveira, André J. Zaharenko, Jose C. de Freitas and Jan Tytgat
      Molecular Pharmacology July 2012, 82 (1) 90-96; DOI: https://doi.org/10.1124/mol.112.078188

P

  1. Pastor-Anglada, Marçal

    1. You have access
      Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia
      Ekaitz Errasti-Murugarren, Paula Fernández-Calotti, Mayke Veyhl-Wichmann, Maximilian Diepold, Itziar Pinilla-Macua, Sandra Pérez-Torras, Helmut Kipp, Hermann Koepsell and Marçal Pastor-Anglada
      Molecular Pharmacology July 2012, 82 (1) 59-67; DOI: https://doi.org/10.1124/mol.111.076992
  2. Peigneur, Steve

    1. You have access
      Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of KV Channels
      Steve Peigneur, Diego J. B. Orts, Alvaro R. Prieto da Silva, Nancy Oguiura, Malvina Boni-Mitake, Eduardo B. de Oliveira, André J. Zaharenko, Jose C. de Freitas and Jan Tytgat
      Molecular Pharmacology July 2012, 82 (1) 90-96; DOI: https://doi.org/10.1124/mol.112.078188
  3. Peluffo, R. Daniel

    1. You have access
      Membrane Potential-Dependent Inhibition of the Na+,K+-ATPase by para-Nitrobenzyltriethylammonium Bromide
      R. Daniel Peluffo and Joshua R. Berlin
      Molecular Pharmacology July 2012, 82 (1) 1-8; DOI: https://doi.org/10.1124/mol.111.077008
  4. Pérez-Torras, Sandra

    1. You have access
      Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia
      Ekaitz Errasti-Murugarren, Paula Fernández-Calotti, Mayke Veyhl-Wichmann, Maximilian Diepold, Itziar Pinilla-Macua, Sandra Pérez-Torras, Helmut Kipp, Hermann Koepsell and Marçal Pastor-Anglada
      Molecular Pharmacology July 2012, 82 (1) 59-67; DOI: https://doi.org/10.1124/mol.111.076992
  5. Pinilla-Macua, Itziar

    1. You have access
      Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia
      Ekaitz Errasti-Murugarren, Paula Fernández-Calotti, Mayke Veyhl-Wichmann, Maximilian Diepold, Itziar Pinilla-Macua, Sandra Pérez-Torras, Helmut Kipp, Hermann Koepsell and Marçal Pastor-Anglada
      Molecular Pharmacology July 2012, 82 (1) 59-67; DOI: https://doi.org/10.1124/mol.111.076992
  6. Pourquier, Philippe

    1. You have access
      The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537
  7. Pouységu, Laurent

    1. You have access
      The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537
  8. Pradere, Ugo

    1. You have access
      Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase
      Christal D. Sohl, Rajesh Kasiviswanathan, Jiae Kim, Ugo Pradere, Raymond F. Schinazi, William C. Copeland, Hiroaki Mitsuya, Masanori Baba and Karen S. Anderson
      Molecular Pharmacology July 2012, 82 (1) 125-133; DOI: https://doi.org/10.1124/mol.112.078758
  9. Prieto da Silva, Alvaro R.

    1. You have access
      Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of KV Channels
      Steve Peigneur, Diego J. B. Orts, Alvaro R. Prieto da Silva, Nancy Oguiura, Malvina Boni-Mitake, Eduardo B. de Oliveira, André J. Zaharenko, Jose C. de Freitas and Jan Tytgat
      Molecular Pharmacology July 2012, 82 (1) 90-96; DOI: https://doi.org/10.1124/mol.112.078188
  10. Puyo, Stéphane

    1. You have access
      The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537

Q

  1. Quach, Patricia

    1. You have access
      Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect
      Patricia Quach, Elaine Gutierrez, Maram Talal Basha, Danuta S. Kalinowski, Philip C. Sharpe, David B. Lovejoy, Paul V. Bernhardt, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology July 2012, 82 (1) 105-114; DOI: https://doi.org/10.1124/mol.112.078964
  2. Quideau, Stéphane

    1. You have access
      The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537

R

  1. Raubertas, Richard

    1. You have access
      Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679
  2. Richardson, Des R.

    1. You have access
      Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect
      Patricia Quach, Elaine Gutierrez, Maram Talal Basha, Danuta S. Kalinowski, Philip C. Sharpe, David B. Lovejoy, Paul V. Bernhardt, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology July 2012, 82 (1) 105-114; DOI: https://doi.org/10.1124/mol.112.078964
  3. Riedel, Thomas

    1. You have access
      Effects of Nucleotide Analogs at the P2X3 Receptor and Its Mutants Identify the Agonist Binding Pouch
      Thomas Riedel, Sara Wiese, Anna Leichsenring and Peter Illes
      Molecular Pharmacology July 2012, 82 (1) 80-89; DOI: https://doi.org/10.1124/mol.112.077818

S

  1. Schinazi, Raymond F.

    1. You have access
      Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase
      Christal D. Sohl, Rajesh Kasiviswanathan, Jiae Kim, Ugo Pradere, Raymond F. Schinazi, William C. Copeland, Hiroaki Mitsuya, Masanori Baba and Karen S. Anderson
      Molecular Pharmacology July 2012, 82 (1) 125-133; DOI: https://doi.org/10.1124/mol.112.078758
  2. Sharpe, Philip C.

    1. You have access
      Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect
      Patricia Quach, Elaine Gutierrez, Maram Talal Basha, Danuta S. Kalinowski, Philip C. Sharpe, David B. Lovejoy, Paul V. Bernhardt, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology July 2012, 82 (1) 105-114; DOI: https://doi.org/10.1124/mol.112.078964
  3. Sheehy, Ryan M.

    1. You have access
      Functional Evaluation of a Fluorescent Schweinfurthin: Mechanism of Cytotoxicity and Intracellular Quantification
      Craig H. Kuder, Ryan M. Sheehy, Jeffrey D. Neighbors, David F. Wiemer and Raymond J. Hohl
      Molecular Pharmacology July 2012, 82 (1) 9-16; DOI: https://doi.org/10.1124/mol.111.077107
  4. Sim, Hong May

    1. You have access
      Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299
  5. Simon, Violaine

    1. You have access
      Influence of the Accessory Protein SET on M3 Muscarinic Receptor Phosphorylation and G Protein Coupling
      Violaine Simon, Sukru S. Oner, Joelle Cohen-Tannoudji, Andrew B. Tobin and Stephen M. Lanier
      Molecular Pharmacology July 2012, 82 (1) 17-26; DOI: https://doi.org/10.1124/mol.111.075523
  6. Singh, Satyakam

    1. You have access
      Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299
  7. Sohl, Christal D.

    1. You have access
      Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase
      Christal D. Sohl, Rajesh Kasiviswanathan, Jiae Kim, Ugo Pradere, Raymond F. Schinazi, William C. Copeland, Hiroaki Mitsuya, Masanori Baba and Karen S. Anderson
      Molecular Pharmacology July 2012, 82 (1) 125-133; DOI: https://doi.org/10.1124/mol.112.078758
  8. Sun, Yueli

    1. You have access
      Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299

T

  1. Talele, Tanaji T.

    1. You have access
      Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299
  2. Tan, Yejun

    1. You have access
      Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679
  3. Thompson, G. Marie

    1. You have access
      Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679
  4. Thompson, John R.

    1. You have access
      Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679
  5. Tikhonov, Denis B.

    1. You have access
      Architecture and Pore Block of Eukaryotic Voltage-Gated Sodium Channels in View of NavAb Bacterial Sodium Channel Structure
      Denis B. Tikhonov and Boris S. Zhorov
      Molecular Pharmacology July 2012, 82 (1) 97-104; DOI: https://doi.org/10.1124/mol.112.078212
  6. Tobin, Andrew B.

    1. You have access
      Influence of the Accessory Protein SET on M3 Muscarinic Receptor Phosphorylation and G Protein Coupling
      Violaine Simon, Sukru S. Oner, Joelle Cohen-Tannoudji, Andrew B. Tobin and Stephen M. Lanier
      Molecular Pharmacology July 2012, 82 (1) 17-26; DOI: https://doi.org/10.1124/mol.111.075523
  7. Tytgat, Jan

    1. You have access
      Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of KV Channels
      Steve Peigneur, Diego J. B. Orts, Alvaro R. Prieto da Silva, Nancy Oguiura, Malvina Boni-Mitake, Eduardo B. de Oliveira, André J. Zaharenko, Jose C. de Freitas and Jan Tytgat
      Molecular Pharmacology July 2012, 82 (1) 90-96; DOI: https://doi.org/10.1124/mol.112.078188

V

  1. Veyhl-Wichmann, Mayke

    1. You have access
      Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia
      Ekaitz Errasti-Murugarren, Paula Fernández-Calotti, Mayke Veyhl-Wichmann, Maximilian Diepold, Itziar Pinilla-Macua, Sandra Pérez-Torras, Helmut Kipp, Hermann Koepsell and Marçal Pastor-Anglada
      Molecular Pharmacology July 2012, 82 (1) 59-67; DOI: https://doi.org/10.1124/mol.111.076992

W

  1. Wiemer, David F.

    1. You have access
      Functional Evaluation of a Fluorescent Schweinfurthin: Mechanism of Cytotoxicity and Intracellular Quantification
      Craig H. Kuder, Ryan M. Sheehy, Jeffrey D. Neighbors, David F. Wiemer and Raymond J. Hohl
      Molecular Pharmacology July 2012, 82 (1) 9-16; DOI: https://doi.org/10.1124/mol.111.077107
  2. Wiese, Sara

    1. You have access
      Effects of Nucleotide Analogs at the P2X3 Receptor and Its Mutants Identify the Agonist Binding Pouch
      Thomas Riedel, Sara Wiese, Anna Leichsenring and Peter Illes
      Molecular Pharmacology July 2012, 82 (1) 80-89; DOI: https://doi.org/10.1124/mol.112.077818
  3. Wong, Kenny K.

    1. You have access
      Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679
  4. Wood, Harold B.

    1. You have access
      Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679

X

  1. Xie, Jing-dun

    1. You have access
      Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299

Y

  1. Yu, Qing

    1. You have access
      Muscarinic Type 3 Receptor Induces Cytoprotective Signaling in Salivary Gland Cells through Epidermal Growth Factor Receptor Transactivation
      Mikihito Kajiya, Isao Ichimonji, Christine Min, Tongbo Zhu, Jun-O Jin, Qing Yu, Soulafa A. Almazrooa, Seunghee Cha and Toshihisa Kawai
      Molecular Pharmacology July 2012, 82 (1) 115-124; DOI: https://doi.org/10.1124/mol.111.077354

Z

  1. Zaharenko, André J.

    1. You have access
      Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of KV Channels
      Steve Peigneur, Diego J. B. Orts, Alvaro R. Prieto da Silva, Nancy Oguiura, Malvina Boni-Mitake, Eduardo B. de Oliveira, André J. Zaharenko, Jose C. de Freitas and Jan Tytgat
      Molecular Pharmacology July 2012, 82 (1) 90-96; DOI: https://doi.org/10.1124/mol.112.078188
  2. Zhang, Xu

    1. You have access
      Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299
  3. Zhao, Xiao-qin

    1. You have access
      Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299
  4. Zhorov, Boris S.

    1. You have access
      Architecture and Pore Block of Eukaryotic Voltage-Gated Sodium Channels in View of NavAb Bacterial Sodium Channel Structure
      Denis B. Tikhonov and Boris S. Zhorov
      Molecular Pharmacology July 2012, 82 (1) 97-104; DOI: https://doi.org/10.1124/mol.112.078212
  5. Zhu, Tongbo

    1. You have access
      Muscarinic Type 3 Receptor Induces Cytoprotective Signaling in Salivary Gland Cells through Epidermal Growth Factor Receptor Transactivation
      Mikihito Kajiya, Isao Ichimonji, Christine Min, Tongbo Zhu, Jun-O Jin, Qing Yu, Soulafa A. Almazrooa, Seunghee Cha and Toshihisa Kawai
      Molecular Pharmacology July 2012, 82 (1) 115-124; DOI: https://doi.org/10.1124/mol.111.077354
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 82 (1)
Molecular Pharmacology
Vol. 82, Issue 1
1 Jul 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics